InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Discover the detailed record of transactions filed by Ahlberg Gregory A, Chief Executive Officer. Insider active across 1 companies, notably Abbott Laboratories. In total, 6 filings have been recorded. The latest transaction was disclosed on 28 February 2022 (Retenue fiscale). Regulator: SEC (Form 4). The full history is free.
Declarations6 total
€280,3782,561 shares@ €109.47980.0001% mcap33.4% of flow
Common shares without par value
SEC:0001415889-22-002184:0·
011,647 shares0
Common shares without par value
SEC:0001415889-22-001728:0·
€256,8516,000 shares@ €42.80850.0001% mcap92.0% of flow
Common shares without par value
SEC:0001415889-21-005270·
€256,8516,000 shares@ €42.80850.0001% mcap30.6% of flow
Common shares without par value
SEC:0001415889-21-005270:0·
€22,453220 shares@ €102.06080.0000% mcap8.0% of flow
Common shares without par value
SEC:0001415889-21-004754·
€22,453220 shares@ €102.06080.0000% mcap2.7% of flow
Common shares without par value
SEC:0001415889-21-004754:0·
6 of 6 declarations
About Ahlberg Gregory A
Gregory A. Ahlberg is the Chief Executive Officer at Abbott Laboratories. He oversees the company's operations and is responsible for growth strategy. His role is crucial to ensure Abbott's success in the pharmaceutical sector.
